| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917766 | Radiotherapy and Oncology | 2016 | 6 Pages |
Abstract
In a large group of patients treated with chemoradiation for locally advanced NSCLC, heart dose was not found to be associated with early survival outcomes when lung dose was taken into account. Nevertheless, based on the known adverse effects of radiotherapy on vasculature and cardiac function, dose to the heart should be minimized during radiotherapy planning.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Susan L. Tucker, Anwen Liu, Daniel Gomez, Ling Long Tang, Pamela Allen, Jinzhong Yang, Zhongxing Liao, David Grosshans,